Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-50,000
Closed -$158K 4470
2024
Q3
$158K Sell
50,000
-99,000
-66% -$291K ﹤0.01% 4200
2024
Q2
$422K Buy
+149,000
New +$1.06M ﹤0.01% 3731
2022
Q3
Sell
-30,000
Closed -$757K 5242
2022
Q2
$757K Buy
+30,000
New +$897K ﹤0.01% 3806
2021
Q3
Sell
-20,200
Closed -$2.16M 5003
2021
Q2
$2.16M Buy
+20,200
New +$1.99M ﹤0.01% 2864

Other funds holding CRNC

David Shaw's CRNC Position: Q2 2026 in Review

David Shaw reduced its Cerence (CRNC) stake by 40% in Q2 2026, selling an estimated $1.38M and leaving 214,328 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #3041.

David Shaw first reported a position in CRNC in Q4 2019 and has held it in 22 quarters since. The position peaked at $14.6M in Q4 2024. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • David Shaw held 214,328 shares of Cerence worth $2.43M as of Q2 2026.
  • David Shaw sold 140,850 Cerence shares in Q2 2026, an estimated $1.38M.
  • Cerence made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3041 holding.
  • David Shaw first reported a position in Cerence in Q4 2019 and has held it in 22 quarters since.
  • David Shaw's Cerence position peaked at $14.6M in Q4 2024.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.